Campbell & CO Investment Adviser LLC Mirum Pharmaceuticals, Inc. Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$23.57 - $34.85 $151,767 - $224,399
6,439 New
6,439 $220,000
Q4 2023

Feb 13, 2024
SELL
$27.14 - $34.93 $492,455 - $633,804
-18,145 Reduced 63.54%
10,411 $307,000
Q3 2023

Nov 08, 2023
BUY
$24.63 - $32.85 $334,524 - $446,168
13,582 Added 90.7%
28,556 $902,000
Q2 2023

Aug 11, 2023
BUY
$23.51 - $30.09 $352,038 - $450,567
14,974 New
14,974 $387,000

Others Institutions Holding MIRM

# of Institutions
190
Shares Held
54M
Call Options Held
177K
Put Options Held
167K
View Full List

About Mirum Pharmaceuticals, Inc.

MIRM Quotes by TradingView
  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.52B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email